The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia

Clinical trial NCT07232134 · RECRUITING

Trial details

NCT number: NCT07232134
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

AML (Acute Myelogenous Leukemia)Down Syndrome (DS)

Start date: 2025-07-24
Primary completion: 2030-07-24
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.